Gaithersburg, MD, United States of America

Bing Wang

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bing Wang

Introduction

Bing Wang is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medicine, particularly in the development of therapies for type I interferon-mediated diseases and asthma. With a total of 4 patents, his work has the potential to impact many lives.

Latest Patents

Wang's latest patents include methods for treating subjects with type I IFN-mediated diseases through the administration of fixed doses of anti-interferon alpha receptor antibodies. This patent outlines various methods for prognosing and monitoring disease progression, predicting dosage regimens, and identifying candidate therapeutic agents. Additionally, he has developed methods for reducing exacerbation rates of asthma using the anti-interleukin-5 receptor antibody benralizumab, which aims to improve the quality of life for asthma patients.

Career Highlights

Throughout his career, Bing Wang has worked with prominent companies such as AstraZeneca and MedImmune Limited. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Wang has collaborated with notable colleagues, including Lorin Roskos and Christine K Ward. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Bing Wang's contributions to medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…